A carregar...
Role of denileukin diftitox in the treatment of persistent or recurrent cutaneous T-cell lymphoma
Denileukin diftitox (Ontak(®)) is indicated for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma (CTCL), a rare lymphoproliferative disorder of the skin. Denileukin diftitox was the first fusion protein toxin approved for the treatment of a human disease. This fusion...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3004568/ https://ncbi.nlm.nih.gov/pubmed/21188096 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|